Show simple item record

Authordc.contributor.authorPikov, Víctor 
Authordc.contributor.authorSridhar, Arun 
Authordc.contributor.authorLara Peñaloza, Hernán 
Admission datedc.date.accessioned2018-09-06T19:01:30Z
Available datedc.date.available2018-09-06T19:01:30Z
Publication datedc.date.issued2018-05-01
Cita de ítemdc.identifier.citationFrontiers in Physiology Volume: 9 Article Number: 459es_ES
Identifierdc.identifier.other10.3389/fphys.2018.00459
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/151516
Abstractdc.description.abstractThe polycystic ovary syndrome (PCOS) is the most prevalent ovarian pathology in women, with excessive sympathetic activity in the superior ovarian nerve (SON) playing an important role in inducing the PCOS symptoms in the rats and humans. Our previous studies have shown that surgical transection of the SON can reverse the disease progression, prompting us to explore the effect of the kilohertz frequency alternating current (KHFAC) modulation as a method of reversible non-surgical suppression of the nerve activity in the rodent model of PCOS. 56 animals were randomly allocated to three groups: the Control group (n = 18), the PCOS group (n = 15), and the PCOS + KHFAC group (n = 23). The physiological, anatomical, and biochemical parameters of ovarian function were evaluated during the progression of the experimentally-induced PCOS and during long-term KHFAC modulation applied for 2-3 weeks. The KHFAC modulation has been able to reverse the pathological changes in assessed PCOS parameters, namely the irregular or absent estrous cycling, formation of ovarian cysts, reduction in the number of corpora lutea, and ovarian norepinephrine concentration. The fertility capacity was similar in the PCOS and the PCOS C KHFAC groups, indicating the safety of KHFAC modulation approach. In summary, these results suggest that the KHFAC modulation approach of suppressing the SON activity could become a useful treatment modality for PCOS and potentially other pathological ovarian conditions.es_ES
Patrocinadordc.description.sponsorshipGlaxoSmithKline/Galvani Bioelectronics COL100035449es_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherFrontiers Media SAes_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceFrontiers in Physiologyes_ES
Keywordsdc.subjectSuperior ovarian nervees_ES
Keywordsdc.subjectKilohertz frequency alternating currentes_ES
Keywordsdc.subjectHigh-frequency stimulationes_ES
Keywordsdc.subjectHigh-frequency blockes_ES
Keywordsdc.subjectPolycystic ovary syndromees_ES
Títulodc.titleHigh-frequency electrical modulation of the superior ovarian nerve as a treatment of polycystic ovary syndrome in the Rates_ES
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorrgfes_ES
Indexationuchile.indexArtículo de publicación ISIes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile